1Tassorelli C, Costa A, Blandini F, et al. Effect of nitric oxide donors on the central nervous system-nitroglycer in studies in the rat. Funct Neurol,2000,15 (3) : 19-27
3Radi R, Backman JS, Bush KM, et al. peroxynitrite-induced membrane lipid peroxidation:the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys, 1991,288(2) :481-487
5Go A S,Mozaffarian D, Roger V L. American heartassociation statistics committee and stroke statisticssubcommittee. Heart disease and stroke statistics-2013update: A report from the american heart association [J].Circulation, 2008,117(4): e25-el46.
6Erin Burke, Steven C. Cramer biomarkers and predictorsof restorative therapy effects after stroke [J] Curr NeurolNeurosciRep, 2013, 13: 329.
7Lamers K J,Vos P, Verbeek M M, et al. Protein S100-B,neuron specific enolase (NSE), myelin basic protein(MBP) and glial fibrillary acidic protein (GFAP) incerebrospinal fluid (CSF) and blood of neurologicalpatients [J]. Brain Res Bull, 2003,61(3): 261-264.
8Popoli P, Pintor A,Domeniei M R. Blockade of striataladenosine A2A receptor reduces, tlirougli a presynapticmeclianism, quinolinic acid-induced excitotoxicity:possible relevance to neuroprotective interventions inneurodegenerative diseases of the striatum [J]. J Neurosci,2002,22(5): 1967-1975.
9Urwylcr S A,Schuctz P, Fluri F,et al. Prognostic value ofcopeptin: one-year outcome in patients with acute stroke[J]. Stroke, 2010, 41(7): 1564-1567.
10Rallidis L S, Zolindaki M G, Vikelis M. Elevated solublein-tercellular adhesion molecules-1 levels are associatedwith poor short-term prognosis in middle-aged patientswith acute ischemic stroke [J]. Int J Cardiol, 2009,132(2):216-221.
